New Insights into the Pathophysiology and Treatment of Non-Cystic Fibrosis Bronchiectasis

Program Overview

Panel Discussion 

This 30-minute interactive panel discussion with an interprofessional clinical expert panel and an experienced patient with non-cystic fibrosis bronchiectasis (NCFBE) will focus on disease burden, symptom recognition, diagnosis, immunopathology, and emerging therapies for patients with NCFBE.

Link to Module 1

Link to Module 2

Credit Expired

Target Audience

Pulmonology, infectious diseases, primary care, and radiology clinicians managing patients with NCFBE

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Identify the impact of non-cystic fibrosis bronchiectasis (NCFBE) and its exacerbations on patient quality of life
  • Utilize clinical practice guidelines for NCFBE diagnosis
  • Examine emerging treatments targeting the underlying immune-mediated pathophysiologic processes of NCFBE
  • Integrate the unique roles and responsibilities of the interprofessional care team when diagnosing and treating patients with NCFBE

Activity Faculty


Mark L. Metersky, MD, FCCP

Professor, Medicine
Associate Chief of Service, Department of Medicine
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
Director, Center for Bronchiectasis Care
UConn Health
Farmington, CT

Margaret M. Johnson, MD

Margaret M. Johnson, MD

Professor, Medicine
Mayo Clinic College of Medicine and Science
Consultant, Pulmonary Medicine
Mayo Clinic
Jacksonville, FL

Molly Mailes, MSN, RN, MEDSURG-BC

Molly Mailes, MSN, RN, MEDSURG-BC

Nurse Program Coordinator, Adult Cystic Fibrosis
Mayo Clinic
Jacksonville, FL


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources